派林生物：筹划控制权变更事项 股票自6月6日起停牌

Core Viewpoint - The company is planning a change in control, leading to a temporary suspension of its stock trading starting June 6, 2025, to ensure fair information disclosure and protect investor interests [1]. Group 1 - The company received a notification from its controlling shareholder, Qiongcheng Shengbang Yinghao Investment Partnership (Limited Partnership), regarding the planning of a change in control [1]. - The stock will be suspended for trading for a period not exceeding two trading days starting from June 6, 2025 [1]. - The change in control is currently in the planning stage and carries significant uncertainty [1].